Moderna gets the ultimate Wall Street validation: It's being added to the S&P 500
CNN
Moderna, the biotech that became a household name with its Covid-19 vaccine, is getting the ultimate Wall Street validation: It's being added to the S&P 500 index.
S&P made the announcement late Thursday, and shares of Moderna (MRNA) surged 10% Friday morning on the news. The stock is now up nearly 175% this year, giving Moderna a market valuation of more than $100 billion. Moderna's addition to the S&P 500 means that the scores of passively managed mutual funds and exchange-traded funds that mirror the S&P 500 will need to add the company's stock to their portfolios. That's a key reason that the stock was popping Friday.Senate Democrats have confirmed some of President Joe Biden’s picks for the federal bench this week in the face of President-elect Donald Trump’s calls for a total GOP blockade of judicial nominations – in part because several Republicans involved with the Trump transition process have been missing votes.
Donald Trump is considering a right-wing media personality and people who have served on his US Secret Service detail to run the agency that has been plagued by its failure to preempt two alleged assassination attempts on Trump this summer, sources familiar with the president-elect’s thinking tell CNN.